Whole-body MRI scans have risen to prominence for their alleged ability to catch many health conditions early. But are they ...

Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an ...

The  (MSAA) is pleased to provide vital services and resources to individuals affected by MS, their families, and care ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...

New research links endometriosis to autoimmune diseases, revealing shared mechanisms that may lead to earlier diagnosis and ...

US biotech fund BVF Parners has sold its stake in drug developer Syntara, thus exiting all of its ASX life sciences exposures ...

Most fault diagnosis methods require that the source and target machines’ fault classes should overlap and the number of samples should be comparable. However, such assumptions are unrealistic in the ...

There were approximately 725,000 new cases and 664,000 deaths worldwide due to hepatocellular carcinoma (HCC) in 2020. HCC comprises 75%-85% of primary liver cancer cases and is the fourth-leading ...

Clinical trials for relapsing multiple sclerosis (MS) have historically used annualised relapse rate (ARR) or confirmed disability accrual (CDA) as endpoints. Recently, several studies 1–3 have ...

Desiree Lama is a 20-something-year-old PhD student living in Austin, Texas. She was diagnosed with relapsing-remitting multiple sclerosis during high school at only 17 years old but began ...